Longevity Health Holdings's latest marketcap:
As of 07/05/2025, Longevity Health Holdings's market capitalization has reached $3.62 M. According to our data, Longevity Health Holdings is the 44711th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.62 M |
| Revenue (ttm) | 560,671 |
| Net Income (ttm) | -8,603,169 |
| Shares Out | 1.48 M |
| EPS (ttm) | -11.19 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Longevity Health Holdings's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $3.62 M | -37.96% | 44711 |
| 12/31/2024 | $5.83 M | -93.37% | 40334 |
| 12/29/2023 | $87.94 M | 23927 |
Company Profile
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. is a bio-aesthetics company specializing in innovative skincare and haircare solutions. Formerly known as Carmell Corporation, the company rebranded in March 2025 and is headquartered in Pittsburgh, Pennsylvania.
Key Technologies & Products
- Carmell Secretome: A proprietary blend of growth factors and proteins derived from allogeneic human platelets, designed to enhance skin and hair health.
- Microemulsion Formulation: A breakthrough delivery system that enables the effective transport of both lipophilic and hydrophilic ingredients without using the "Foul Fourteen"—14 potentially harmful excipients commonly found in cosmetics.
- Product Lines: The company is expanding its portfolio with dedicated men's products and topical haircare solutions.
Strategic Partnerships
Longevity Health Holdings has a licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics, furthering its commitment to cutting-edge biotechnology.
Company Background
Founded in 2008, the company has evolved from Carmell Corporation to Longevity Health Holdings, Inc., reflecting its growth and focus on longevity-driven health innovations.
Frequently Asked Questions
-
What is Longevity Health Holdings's (XAGE) current market cap?As of 07/05/2025, Longevity Health Holdings (including the parent company, if applicable) has an estimated market capitalization of $3.62 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Longevity Health Holdings (XAGE) rank globally by market cap?Longevity Health Holdings global market capitalization ranking is approximately 44711 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.